Ask AI
ProCE Banner Series

Thrombotic Risk in Patients With Polycythemia Vera | Identify When to Intervene With Jakafi® (ruxolitinib)

Key Takeaways

  • Determine a patient’s Hct level, WBC count, and risk of a thrombotic event
  • Evaluate treatment options in PV
  • Discuss potential patient outcomes

All Events

Thrombotic Risk in Patients With Polycythemia Vera | Identify When to Intervene With Jakafi® (ruxolitinib)

Upcoming Events

September

24

2025

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Additional Info

Acknowledgement

Sponsored By

Incyte

Incyte